ARA-290 is a variant of erythropoietin that has been shown to reduce inflammation by targeting paracrine signaling and activating innate repair receptors. Research indicates that ARA-290 may help lower HbA1c levels, improve cholesterol profiles, modulate neuropathic pain, and promote wound healing.